Invesco Ltd. Ionis Pharmaceuticals Inc Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Invesco Ltd. holds 256,235 shares of IONS stock, worth $10.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

256,235

Previous 874,834 70.71%

Holding current value

$10.6 Million

Previous $26.4 Million 61.65%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$25.51 - $40.0 $15.8 Million - $24.7 Million	-618,599 Reduced 70.71%	256,235 $10.1 Million
Q1 2025 May 12, 2025	BUY	$30.17 - $34.97 $2.6 Million - $3.02 Million	86,235 Added 10.94%	874,834 $26.4 Million
Q4 2024 Feb 13, 2025	SELL	$33.73 - $40.36 $732,008 - $875,892	-21,702 Reduced 2.68%	788,599 $27.6 Million
Q3 2024 Nov 12, 2024	SELL	$40.06 - $51.86 $6.35 Million - $8.23 Million	-158,616 Reduced 16.37%	810,301 $32.5 Million
Q2 2024 Aug 13, 2024	BUY	$36.45 - $47.7 $19.2 Million - $25.1 Million	526,030 Added 118.77%	968,917 $46.2 Million
Q1 2024 May 14, 2024	BUY	$42.03 - $53.55 $9.96 Million - $12.7 Million	236,986 Added 115.1%	442,887 $19.2 Million
Q4 2023 Feb 12, 2024	BUY	$43.39 - $51.63 $3.24 Million - $3.86 Million	74,734 Added 56.98%	205,901 $10.4 Million
Q3 2023 Nov 13, 2023	BUY	$38.5 - $47.13 $55,786 - $68,291	1,449 Added 1.12%	131,167 $5.95 Million
Q2 2023 Aug 11, 2023	SELL	$34.73 - $43.33 $6.46 Million - $8.06 Million	-186,002 Reduced 58.91%	129,718 $5.32 Million
Q1 2023 May 12, 2023	SELL	$33.58 - $41.2 $225,892 - $277,152	-6,727 Reduced 2.09%	315,720 $11.3 Million
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $1.01 Million - $1.27 Million	27,248 Added 9.23%	322,447 $12.2 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $1.12 Million - $1.5 Million	-30,786 Reduced 9.44%	295,199 $13.1 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $5.9 Million - $8 Million	185,993 Added 132.86%	325,985 $12.1 Million
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $231,570 - $287,060	7,750 Added 5.86%	139,992 $5.19 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $233,383 - $319,866	-9,113 Reduced 6.45%	132,242 $4.02 Million
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $6.68 Million - $8.08 Million	-199,258 Reduced 58.5%	141,355 $4.74 Million
Q2 2021 Aug 17, 2021	SELL	$34.54 - $47.25 $69.7 Million - $95.4 Million	-2,018,821 Reduced 85.56%	340,613 $13.6 Million
Q1 2021 May 17, 2021	SELL	$42.51 - $63.78 $43.6 Million - $65.4 Million	-1,025,435 Reduced 30.29%	2,359,434 $106 Million
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $36.8 Million - $49 Million	813,228 Added 31.62%	3,384,869 $191 Million
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $11 Million - $14.6 Million	231,896 Added 9.91%	2,571,641 $122 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $49,286 - $64,224	-1,052 Reduced 0.04%	2,339,745 $138 Million
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $591,926 - $902,118	-14,229 Reduced 0.6%	2,340,797 $111 Million
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $1.17 Million - $1.41 Million	-21,637 Reduced 0.91%	2,355,026 $142 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $6.21 Million - $7.58 Million	105,124 Added 4.63%	2,376,663 $142 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $136 Million - $189 Million	2,191,974 Added 2754.95%	2,271,539 $146 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $1.57 Million - $2.4 Million	29,583 Added 59.19%	79,565 $6.46 Million
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $2.17 Million - $2.98 Million	49,982 New	49,982 $2.7 Million

Others Institutions Holding IONS

# of Institutions

406

Shares Held

148M

Call Options Held

872K

Put Options Held

432K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.85B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account